Standard Chartered to Cut Over 15 of Corporate Functions Roles in Push for Higher Returns Escalation in Ukraine Conflict Hypersonic Missile Attack Stirs Market Geopolitical Concerns April Jobs Report Preview Labor Market Seen as Cooling but Resilient London Stock Exchange Group Reports Income Growth Driven by Tradeweb Tulsi Gabbard Resigns as Director of National Intelligence Marking Latest Cabinet Departure The Pitfalls of Performance Chasing Why LongTerm Strategy Matters Over ShortTerm Returns Highwoods Properties Inc HIW Q1 2026 Earnings EPS Surges 161 Above Estimates SMCI Q1 2026 Earnings Strong EPS Beat Drives Stock Rally TTEC Holdings Inc TTEC Q1 2026 Earnings Widening EPS Miss Sends Shares Lower Azitra Q1 2026 Earnings Significant EPS Miss Amid Development Stage Operations iHeartMedia Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Kinetik Holdings KNTK Slips 287 Support Test Looms as Energy Midstream Faces Pressure Youxin Technology Ltd YAAS Edges Higher as Price Approaches Resistance Olin Corporation OLN Edges Lower Consolidating Between Key Support and Resistance Levels Luda Technology Group LUD Surges 395 as Shares Test Key Resistance Near 469 Mountain Lake Acquisition Corp II Warrants MLAAW Dip to 026 as Warrants Test Technical Floor Tempus AI Launches ArteraAI Prostate Test Pioneering Digital Pathology Algorithm for Prostate Cancer MYFW Q1 2026 Earnings Strong Earnings Beat with 4279 Surprise AI Infrastructure Acquisition Corp AIIA Holds Steady at 1012 as Trading Action Remains Subdued FitLife Brands Inc FTLF Q1 2026 Earnings EPS Beats Estimates by 33 Despite Negative Stock Reaction CETX Q3 2024 Earnings Deep EPS Miss Raises Concerns Amid Operational Challenges Boyd Gaming BYD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment DX Q1 2026 Earnings EPS Misses Estimates Amid Interest Rate Volatility HTFC Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Envista Holdings Q1 2026 Earnings Earnings Beat Masks Lingering Headwinds as Stock Slips CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics